{
    "root": "312c1d44-3b8d-010e-e063-6294a90a876c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Trazodone Hydrochloride",
    "value": "20250325",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        }
    ],
    "indications": {
        "text": "trazodone selective serotonin reuptake inhibitor indicated treatment major depressive disorder ( mdd ) ( 1 ) .",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "starting dose : 150 mg divided doses daily . may increased 50 mg per day every three four days . maximum dose : 400 mg per day divided doses ( 2 ) . trazodone hydrochloride tablets taken shortly meal light snack ( 2 ) . tablets swallowed whole broken half along score line , chewed crushed ( 2 ) . discontinued , gradual dose reduction recommended ( 2 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "trazodone hydrochloride tablets usp , 50 mg white off-white , round-shape , biconvex beveled tablets , bisect one side plain side . bisected side tablet debossed ' 8 ' upper side bisect '05 ' lower side bisect supplied follows : directions using correct score breaking tablet , please refer following : -for 50 mg , break score either left right side tablet ( one-third tablet ) . ndc : 70518-3290-00 ndc : 70518-3290-01 ndc : 70518-3290-02 ndc : 70518-3290-03 ndc : 70518-3290-04 ndc : 70518-3290-05 packaging : 30 1 blister pack packaging : 30 1 blister pack packaging : 30 1 blister pack packaging : 90 1 bottle plastic packaging : 90 1 bottle plastic packaging : 30 1 bottle plastic store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] . dispense child-resistant closure tight , light-resistant container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "none ( 4 ) . concomitant monoamine oxidase inhibitors ( maois ) , within 14 days stopping maois ( 4 ) .",
    "indications_original": "Trazodone is a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 ).",
    "contraindications_original": "Starting dose:      150 mg in divided doses daily. May be increased by 50 mg per day every      three to four days. Maximum dose: 400 mg per day in divided doses ( 2 ). Trazodone      hydrochloride tablets should be taken shortly after a meal or light snack      ( 2 ). Tablets should      be swallowed whole or broken in half along the score line, and should not      be chewed or crushed ( 2 ). When      discontinued, gradual dose reduction is recommended ( 2 ).",
    "warningsAndPrecautions_original": "Trazodone Hydrochloride Tablets USP, 50 mg are white to off-white, round-shape, biconvex beveled tablets, bisect on one side and plain on other side. The bisected side of tablet is debossed with '8' on upper side of bisect and '05' on lower side of bisect and are supplied as follows:\n                  Directions for using the correct score when breaking the tablet, please refer to the\n                  following:\n                  -For 50 mg, break the score on either the left or right side of the tablet (one-third of a\n                  tablet).\n                  \n                  NDC: 70518-3290-00\n                  NDC: 70518-3290-01\n                  NDC: 70518-3290-02\n                  NDC: 70518-3290-03\n                  NDC: 70518-3290-04\n                  NDC: 70518-3290-05\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC \n                  \n                  \n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense with a child-resistant closure in a tight, light-resistant container.\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "None ( 4 ). Concomitant use of monoamine oxidase inhibitors (MAOIs), or use within 14 days of stopping MAOIs ( 4 ).",
    "drug": [
        {
            "name": "Trazodone Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        }
    ]
}